Filing Details

Accession Number:
0001209191-18-057053
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-11-02 20:02:47
Reporting Period:
2018-10-31
Accepted Time:
2018-11-02 20:02:47
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
353569 Quidel Corp QDEL In Vitro & In Vivo Diagnostic Substances (2835) 942573850
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1406652 C Douglas Bryant 12544 High Bluff Drive, Suite 200
San Diego CA 92130
President & Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-10-31 7,217 $12.36 301,530 No 4 M Direct
Common Stock Disposition 2018-10-31 7,217 $65.10 294,313 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option Disposition 2018-10-31 7,217 $0.00 7,217 $12.36
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
8,745 2013-02-02 2019-02-02 No 4 M Direct
Footnotes
  1. The weighted average sale price for these transactions was $65.10 per share, with a range of $65.00 to $65.49. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price.